Medtronic plc (MDT)
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Medtronic (MDT) closed the most recent trading day at $91.12, moving +0.1% from the previous trading session.
MDT vs. ABT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, Medtronic (MDT) closed at $89.36, marking a +0.57% move from the previous day.
Medtronic: Undervalued Dividend Aristocrat With High Margins
Medtronic remains an attractive investment due to its diversified revenue streams, robust product pipeline and improving margins. MDT's growth is driven by strong performance in Neuroscience, Cardiovascular, and Diabetes care, with significant international revenue growth and a promising product pipeline. Trading below its historical valuation, MDT offers a compelling opportunity for conservative investors seeking quality at a reasonably low price.
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?
The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.
The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International
JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.
Medtronic (MDT) Advances But Underperforms Market: Key Facts
Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Company says the smallest knock can impact batteries by damaging internal electronics
Reasons to Retain Medtronic Stock in Your Portfolio Now
Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.
Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock
Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.
